•••
Dr. Reddy's �;•
July 30, 2020
To,
The Secretary
BSE Limited
National Stock Exchange oflndia Limited
Dear Sir/Madam,
Dr. Raddy's Laboratories Ltd.
8-2-337, Road No. 3, Banjara Hills,
Hyderabad - 500 034, Telangana,
India.
CIN: L85195TG1984PLC004507
Tel | :+91 40 4900 2900 |
Fax | :+91 40 4900 2999 |
Email :mail@drreddys.com www.drreddys.com
Sub: Newspaper advertisement regarding financial results ofQl FY2021
Pursuant to Regulation 47 ofthe Securities and Exchange Board ofIndia (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended, please find enclosed copies of newspaper advertisement regarding the financial results ofthe company for the quarter ended June 30, 2020 as published in Business Standard and Andhra Prabha on July 30, 2020.
This is for your information and records.
With regards,
�. .
Sar�� Po ar omp' Secretary
� | r | Place : | Chennai | r | P.Dinakara Babu |
Date : | 28.07.2020 | Company Secretary |
Business Standard - July 30, 2020
Dr.Reddy's t'
SI.
No.
1
2
3
4
5
6
7
8
Extract of unaudited flnanclal results of Dr. Reddy's Laboratories Limited and Its subsidiaries for the quarter
ended 30 June 2020 prepared In compliance with Indian Accounting Standards
All amounts in Indian Rupees millions | |||
Quarter | Consolidated | ||
Year | Quarter | ||
Particulars | ended | ended | ended |
30.06.2020 | 31.03.2020 | 30.06.2019 | |
(Unaudited) | (Audited) | (Unaudited) | |
Total Income from Operations | 44,265 | 175,170 | 38,582 |
Net Profit for the period (before Tax, Exceptional and/or Extraordinary items) | 9,005 | 18,857 | 8,693 |
Net Profit for the period before tax (after Exceptional and/or Extraordinary items) | 9,005 | 18,857 | 8,693 |
Net Profit for the period after tax (after Exceptional and/or Extraordinary items) | 5,946 | 20,260 | 6,765 |
Total Comprehensive Income for the period | 6,728 | 19,610 | 6,472 |
Equity Share Capital | 831 | 831 | 831 |
Reserves (excluding Revaluation Reserve) | 155,157 | ||
Earnings per share (In Rupees) per Rs. Si• share | 35.87 | 122.22 | 40.81 |
Basic | |||
Diluted | 35.78 | 121.99 | 40.74 |
SI.
No.Particulars
- Total Income from Operations
- Net Profit for the period (before Tax, Exceptional and/or Extr.1ordinary items)
-
Net Profit for the period before tax (after Exceptional and/or Extraordinary items)
4 Net Profit for the period after tax (after Exceptional and/or Extraordinary items) 5 Total Comprehensive Income for the period
6 Equity Share Capital
7 Reserves (excluding Revaluation Reserve)
8 Earnings per share (In Rupees) per Rs. 5/· share Basic
Diluted
Notes:
Quarter | Standalone | |
Year | Quarter | |
ended | ended | ended |
30.06.2020 | 31.03.2020 | 30.06.2019 |
(Unaudited) | (Audited) | (Unaudited) |
32,444 | 118,504 | 25,087 |
13,617 | 27,758 | 6,930 |
13,617 | 27,758 | 6,930 |
9,502 | 29,377 | 5,481 |
9,733 | 28,941 | 5,441 |
831 | 831 | 831 |
151,088 | ||
57.31 | 177.23 | 33.06 |
57.18 | 176.88 | 33.01 |
- The above is an extract of the detailed 1ormat of Quarterly Financial Results filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing and Other Disclosure Requirements) Regulations, 2015. The full format of the Quarterly Financial Results are available on the Stock Exchanges website: www.bseindia.com and www.nseindia.com and also on the Company's website: www.drreddys.com.
- The unaudited resutts have been reviewed by the Audit Committee of the Board and approved by the Board of Directors of the Company at their meeting held on 29July 2020.
By order of the Board For Dr. Raddy's Laboratories Limited
Place : Hyderabad
Date : 29July 2020G V Prasad Co-Chairman & Managing Direcor
Dr. REDDY'S LABORATORIES LIMITED
Regd. Office: 8 -2-337, Road No.3, Banjara HIiis, Hyderabad• 500 034, Telangana, India
CIN: L8 5195TG1984PLC004507, Tel: 91404900 2900, Fax: 91404900 2999 email: shares@drreddys.com, website: www.drreddys.com
n®�Pa,milta,a@,/11,a,
Rail Vikas Nigam Limited
(A Government of India Enterprise)
RAIL VIKAS NIGAM LIMITED
(A Govt. of India Enterprise)
office: 1st Floor, August Kranti Bhawan, Bhlkajl Cama Place, R. K. Puram, New Delhi, South Delhi -110066E-mail:investors@rvnl.orgWebsite:www.rvnl.org;CIN:L74999DL2003G01118633
,ONE & CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED ON MARCH 31, 2020 | |||||||||||
Standalone | (, II llldlsuce,t EPS) | ||||||||||
Quarter Ended | Consolidated | ||||||||||
31.03.2020 | Year | Ended | Quarter Ended | Year | Ended | ||||||
31.12.2019 | 31.03.2019 | 31.03.2020 | 31.03.2019 | 31.03.2020 | 31.12.2019 | 31.03.2019 | 31.03.2020 | 31.03.2019 | |||
(Unaudited) | (Unaudited) | (Unaudited) | (Audlled) | (Audited) | (Unaudited) | (Unaudited) | (UnaudHedJ | (AudHedJ | (Audited) | ||
4,22,067.49 | 3,69,926.50 | 3,41,844.49 | 14,53,057.97 | 10,06,007.06 | 4,22,067.49 | 3,69,926.50 | 3,42,705.56 | 14,53,057.97 | 10,06,868.13 | ||
5 657.92 | 7 385.76 | 6 219.09 | 26 557.86 | 27 263.21 | 5 661.33 | 7 387.34 | 6 221.86 | 24 568.45 | 25 524.19 | ||
4 27 725.41 | 3 77 312.26 | 3 48 063.58 14 79,615.83 | 1D,33 270.27 | 4 27 728.82 | 3,77,313.84 | 3,48,927.42 | 14,77,626.42 | 10 32 392.32 | |||
24,875.07 | 27,986.63 | 22,815.32 | 99,084.03 | 75,831.26 | 29,879.23 | 18,541.32 | 23,371.22 | 95,431.66 | 83,948.26 | ||
19,730.31 | 19,793.60 | 18,583.91 | 78,985.97 | 60,658.65 | 24,734.15 | 10,348.15 | 19,139.78 | 75,332.27 | 68,774.35 | ||
(loss) | 1,242.35 | 1,242.35 | 1,242.35 | 1,242.35 | |||||||
-161.95 | -32.04 | -154.36 | -204.95 | -154.16 | -161.27 | -32.03 | -154.36 | -204.27 | -154:02 | ||
208502.01 | , | _ 208502.01 | |||||||||
208502.0L.. 208502.01 | 208502.01 | ,-1Q!!.502.Q1 | 208502.01 | 208502.01 | 208502.01 _ 208502.Q.1 |
���- Eks-6��2��of�atitie | 'urr•-�·----- | �s:..aw:i.:a:; | - | - ...... | rnwt- | • | ;I | ||||||||||||||||||||
J | 221009e6 | 2S.08.2020 ....t :,,olr •�140 l�� •ISA�L | 70 �-.,, 163060/- | ||||||||||||||||||||||||
JOSe>� d)t, | !!ici� | �w"6S | �o� | CompanyWill beheld on Thursday the 13 | |||||||||||||||||||||||
�.:> | 526001- | ||||||||||||||||||||||||||
August 2020 | P.M | 111 | ◄ | 22201004 2s.oa.2020 | � �,s 3/4" | •IS4.:l�L | 1990ao.w | ·r, | |||||||||||||||||||
at 03.30 | at the Registered | ||||||||||||||||||||||||||
so�; ;;- a��_,- ��:) | •IS4.):SO. | 19 �o.w | 7541/fJ/- | ||||||||||||||||||||||||
� �6�� .sM a�. :sf;,:JQoSe>� | S | ll19092◄F | 25.08.2020 | t,) | |||||||||||||||||||||||
Office ofthe Company to apProve and take | |||||||||||||||||||||||||||
.� �w"6S 1196:itll !!ioSJ-oe, �o� | for lhe Quarter ended 30111 | June 2020. | "'. | ||||||||||||||||||||||||
6 | 22191011 | 26.08.2020 | .,.1r,6e rro�5 �.:> | •IS4.):SL | 0 | 61060/,- | |||||||||||||||||||||
'o�� �6��. oe.xiru �.:J:O�oSJ-o� | on record the Unaudited Financial Resulls | 273 � ..,, | |||||||||||||||||||||||||
For BKV INDUSTRIES LIMITED | CPROtS-16 | �:l.)�.,. .:i� ��o�e.:i ��.IS. .,,.� ��s- rf6'6tJ-5 | |||||||||||||||||||||||||
; a�. omru 1!9��tx, :i!os'e | Sd/· B. Viral Vishnu | f>r, | |||||||||||||||||||||||||
29.07.2020 | |||||||||||||||||||||||||||
Compliance Officer . | �.,., e-io-io-. | ;:,0..,1>0.:i :lll:i :.0-11:Sic>.:. | �e | :io. 097948-4595� | �:s | �.:ll!Cllll. | __ | ||||||||||||||||||||
GUNTUR | Company SecMtary & | ||||||||||||||||||||||||||
·Ell | , | ||||||||||||||||||||||||||
Andhra Prabha - July 30, 2020 | Dr.Reddys ,.-. | |||||||||||||||||||||||
.,.,.j, | ||||||||||||||||||||||||
Extract of unaudited financial results of Dr. Reddy's Laboratories Limited and Its aubsJdfarles for the quarter | ||||||||||||||||||||||||
ended 30 June 2020 prepared In compliance with Indian Accounting Standards | ||||||||||||||||||||||||
el | All amounts in Indian R•mAes millions·� | |||||||||||||||||||||||
!'-> | consouoatea | w | ||||||||||||||||||||||
SI. | Quarter | Vear | Quarter | "' | ||||||||||||||||||||
Partlcufars | ended | ended | ended | � | ||||||||||||||||||||
No. | 30.06.2020 | 31.03.2020 | 30.06.2019, b5" | |||||||||||||||||||||
(Unaudited) | (Audited) | (Unaudltedf | � | |||||||||||||||||||||
1 | Total Income from Operations | 44.265 | 175,170 | 38.582 | ,., | |||||||||||||||||||
2 | Net Profit for lhe pertod (before Tax, Ex<:eptional and/or Extraordinary Items) | 9,005 | 18,857 | 8.693: | � | |||||||||||||||||||
3 | Net Profit for the perlod before tax (after Exceptional and/or Extraordinary Items} | 9.005 | 18,857 | 8,693 | ":;'3 | |||||||||||||||||||
• | 4 | Net Profit for the period alter tax (after Exceptional and/or Extraordinary items} | 5,946 | 20,260 | 6,765 | � | ||||||||||||||||||
5 | Total COmprehensiVe Income for the period | 6.728 | 19,610 | 6,472 | ||||||||||||||||||||
I | 6 | Equity Share Capital | 831 | 831 | 631 | l3ti | ||||||||||||||||||
7 | Reserves (excluding Revaluation Reserve} | 155,157 | ||||||||||||||||||||||
8 | Eemlngs per ehare (In Rupees) per Rs,. 5/• share | 35.87 | 122.22 | 40.81 'b°b | ||||||||||||||||||||
Basic | ||||||||||||||||||||||||
Diluted | 35,78 | 121.99 | 40,74 | � | ||||||||||||||||||||
·" | ||||||||||||||||||||||||
Quarter | Standalone | Quarter | :'.A | |||||||||||||||||||||
SI. | Year | �� | ||||||||||||||||||||||
No. | Particulars | ended | ended | ended | - | -� | ||||||||||||||||||
30.06.2020 | 31.03.2020 | 30.06.2019 | L,f: | |||||||||||||||||||||
1 | Total Income from Operations | (Unaudited) | (Audited} | (Unaudited) | .,, | |||||||||||||||||||
32,444 | 118,504 | 25,087 | :!!I | |||||||||||||||||||||
2 | Net Profit for the period (before Tax, Exceptional and/or E.xttaordlnary items) | 13,617 | 27,758 | 6,930. | ||||||||||||||||||||
3 | Net Proflt for the period before tax (after Exceptional and/or Extraordinary items) | 13,617 | 27,758 | 6,930 | '� | |||||||||||||||||||
4 | Net Profit for the period after tax (after Exceptional and/or E�ordinary items) | 9,502 | 29,377 | 5,481 | ||||||||||||||||||||
5 | Total Comprehensive Income for the period | 9,733 | 28,941 | 5 441 | , | '::I | ||||||||||||||||||
6 | Equity Share Capital | 831 | 831 | ,831 | ||||||||||||||||||||
7 | Reserves (excluding Revaluation Reserve) | 151.088 | , | |||||||||||||||||||||
8 | Eamlnge per share (In Rupees) per Re | 51· share | 57.31 | 1n.23 | 33 06 | |||||||||||||||||||
Baslc | . | .. | ||||||||||||||||||||||
.:a:....Notes: '"' | DUuted | - | ·� | ,. � - | ·• | • | - 0 • | 57.18 | 17'",.,, l | ..-..nt | ||||||||||||||
- | - | ·-:- | • | �,._ � | ||||||||||||||||||||
1 | The above is an extract of thedetailed format of Quarterly Financial Results filed with theStock Exchanges under Regulation 33 ot the SEBI (Listing | I | ||||||||||||||||||||||
and Other Disclosure Requirements) Regulations, 2015. The full format or the Ouanedy Financial Results are available on the Stock Exchanges | � | |||||||||||||||||||||||
2 | website: www.bseindia.com aod www.nseindia.com and also on the Company's website: www.drreddys.com. | |||||||||||||||||||||||
The unaudited results have been reliewed by theAudit Committee of the Board and approved by the Board of Directors of the Company at their | ||||||||||||||||||||||||
meeting held on 29 July 2020. | By order of the Board | |||||||||||||||||||||||
Place | : | Hyderabad | For Dr. Raddy's Laboratories Limited | |||||||||||||||||||||
GV Prasad | ||||||||||||||||||||||||
Date | : | 29 July2020 | ||||||||||||||||||||||
Co-Chairman & Managing Dir8(:()r | ,•·-:""' | |||||||||||||||||||||||
Dr. REDDY'S LABORATORIES LIMITED | ||||||||||||||||||||||||
Regd. Office: 8-2-337, Road No.3, BanJara HIii, | Hy erabad• 500 034, Tetangana, India | •i•t,• | ||||||||||||||||||||||
i'. | ||||||||||||||||||||||||
s | d | |||||||||||||||||||||||
CIN: L85195TG1984PLC004507, Tel: 91 40 4900 2900, Fax: 91 40 4900 2999 | ,' | ;�.., | ||||||||||||||||||||||
a | ste | . | d | co | ||||||||||||||||||||
m | . | |||||||||||||||||||||||
.____________em 11:_s_hares_...,@drreddys.co_m_,_we1 b_:_www rreddy•_. | _, _,1� |
---------------------------------------------+•,'•;.w•
';,eO;j&" �QJ ���Q
C)d�: 6-3-541/ib.��-500 082.
PLC014332 • www.haritagefoods.in - Tai; 040 - 2�391221/23391222 Fax: 30685458, Email- hfl@herltagefoods.in
���-1o-&t6� �do'salO� sa&>�i��
:it.- 60 ��;s | �Ai 6or:l |
•06�� �� �QQ) | eiocS�O,,,� �� ';,�Q) |
,.- ' ��.)� ���Ii
30-06-202031-03-2020 | 30-06-2019 | 31-03-202030-06-2020 31-03-2020 | |||||
(•4.r r:>) | (es&tS" ��;S) | {e:s�tS" S"�) | <•e.Ar ��;:,) | (veter Ir�) | (es�cS" ��;S) | ||
70728.77 | 79132.97 | 76008.47 | 302926.04 | 68826.38 | 78135.56 | ||
lOI'.>) | 10551.22 | (20692.51) | 2981.51 | (15405.42) | 10287.54 | (20739,53) | |
�) | 10551.22 | (20692.51) | 2981.51 | (15405.42) | 10287.54 | (20739.53) | |
9544.23 | (20989.47) | 1810.03 | (16940.02) | 9395.58 | (21033.04) | ||
.... ---.t | 44711::J ,f? | /�')7')g i:;,Q | ?DA'> ?".I | #'LI IU�A '21\ | "•a◄o1 117 | /'2'>7&H> ,:,1 |
30-06-2019
{e:s�cS"S"'�)
74964.70
3327.31
3327.31
2171.34
"l"lA"'l £'2
31-03-2020i
(.e..r ��:S) ,c- 298391.89''"'°'�11I
(14467.64) :t)i_" I
{14467.64) �"ti I (16000.44) "'�...(:�-::i
1"2'14-4 t: ft�
Attachments
- Original document
- Permalink
Disclaimer
Dr. Reddy's Laboratories Limited published this content on 30 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 August 2020 00:06:18 UTC